- E34.51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E34.51 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E34.51 – other international versions of ICD-10 E34.51 may differ.
ICD-10-CM E34.51 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Complete androgen insensitivity
- de Quervain syndrome
- Goldberg-Maxwell syndrome
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E34.51:
- syndrome > De Quervain\’s
- complete > androgen E34.50
- androgen resistance > with E25.8
- feminizing testis > with E25.8
- complete > androgen insensitivity E34.50
- De Quervain > Syndrome
- Goldberg-Maxwell > Syndrome
- testicular feminization > Syndrome
- feminization syndrome > Testicle, testicular, testis